XBIT Share Price Performance
US$2.66
-1.04 (-28.11%)
Price US$2.66
Share Pricen/a
We're Hopeful That XBiotech (NASDAQ:XBIT) Will Use Its Cash Wisely
Nov 04
XBiotech Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
XBIT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
XBiotech Inc. Key Details
About XBIT
- Founded
- 2005
- Employees
- 88
- CEO
- WebsiteView website
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
